United Kingdom  

WHO set to resume hydroxychloroquine trial in battle against COVID-19

Reuters Wednesday, 3 June 2020
The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: WHO set to resume hydroxychloroquine trial to battle covid-19

WHO set to resume hydroxychloroquine trial to battle covid-19 02:33

World Health Orgnanisation (WHO) said hydroxychloroquine (HCQ) will return to solidarity trial for potential treatment covid-19. The UN body had paused trials of the anti-malarial drug citing a Lancet study. The study had suggested the drug could cause more fatalities among Covid-19 patients. At a...

You Might Like


💡 One News Page Knowledge: Other News Mentions

World Health Organization World Health Organization Specialized agency of the United Nations

WHO Seeks $76 Million For Lebanon After Beirut Blast, Concerned About Coronavirus [Video]

WHO Seeks $76 Million For Lebanon After Beirut Blast, Concerned About Coronavirus

The World Health Organization is passing the hat to assist Lebanon after last week's massive explosion in Beirut. HuffPost reports the WHO appealed for $76 million in aid on Wednesday, following the damage done to Lebanese hospitals, clinics, and medical supplies. HuffPost reports the blast put three hospitals out of operation and has left three others working at partial capacity.

Credit: Wochit News    Duration: 00:38Published

Beirut blast: WHO warns dozens of health facilities 'non-functional'

Of 55 health facilities assessed by the World Health Organization, half are "non-functional".
BBC News
WHO says Lebanese COVID-19 response hard after blast [Video]

WHO says Lebanese COVID-19 response hard after blast

World Health Organization officials on Wednesday warned that Lebanon's COVID-19 response plan has become more difficult to implement in the aftermath of the massive blast that rocked the capital Beirut.

Credit: Reuters Studio    Duration: 01:12Published
Russia approves Covid-19 vaccine 'Sputnik V': Why's the world sceptical? [Video]

Russia approves Covid-19 vaccine 'Sputnik V': Why's the world sceptical?

Russia has become the first country to approve a Covid-19 vaccine and it has been named 'Sputnik V'. Russian President Vladimir Putin said that the vaccine was effective and said that one of his daughters had already been inoculated. The vaccine is administered in two doses and consists of two serotypes of a human adenovirus, each carrying an S-antigen of the new coronavirus, which enter human cells and produce an immune response. However, concerns have been raised from several quarters over the safety and efficacy of the vaccine. Several countries including the US, Canada and Germany have raised questions over the vaccine and said that vaccine production is not a race. What makes matters murky is that the approval comes even before the start of a larger trial involving thousands of participants, commonly known as a Phase III trial. The World Health Organisation said any stamp of approval on a COVID-19 vaccine candidate would require a rigorous safety data review. So why is the world sceptical about Russia's 'Sputnik V'? Watch this video to find out.

Credit: HT Digital Content    Duration: 03:03Published
Alyssa Milano: Hair Loss Caused By COVID-19 [Video]

Alyssa Milano: Hair Loss Caused By COVID-19

A growing number of COVID-19 survivors often referred to as "long-haulers" — people who've been experiencing symptoms for months instead of the average of two weeks the World Health Organization (WHO) says is the usual span — have been sharing their personal experiences with the disease on social media. Oftentimes, they reveal that they're suffering from symptoms that the Centers for Disease Control and Prevention (CDC) do not indicate as COVID-19 symptoms, like hair loss.

Credit: Wochit News    Duration: 00:33Published

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Study: The Most Common Form Of Lung Cancer Is Killing Fewer People In The US [Video]

Study: The Most Common Form Of Lung Cancer Is Killing Fewer People In The US

While the novel coronavirus COVID-19 relentlessly attacks the lungs of millions, there is one bit of bright news regarding deaths from lung cancer. UPI reports a new analysis reveals deaths from non-small cell lung cancer in the US declined by about 3% a year on average between 2006 and 2016. The number of Americans who died from the most common form of lung cancer dropped by 3.2% per year from 2006 through 2013. From 2013 through 2016, it dropped by 6.3% per year.

Credit: Wochit News    Duration: 00:35Published
Pune woman enables kids to learn making Ganesh idols at home amid COVID-19 [Video]

Pune woman enables kids to learn making Ganesh idols at home amid COVID-19

Preparations for Ganesh Chaturthi festival are underway across nation. A lady in Maharashtra's Pune is using unique idea to impart idol making skills to children. Every year, Asmita Andre used to hold Ganesh idol making workshop for kids ahead of Ganesh Chaturthi. This year amid COVID-19 pandemic situation, Asmita decided to supply the idol making material through home delivery. Workshop items are getting delivered with a pamphlet and video link to make it easier for kids at home. The package includes terracotta clay, seeds, pamphlet etc.

Credit: ANI    Duration: 02:12Published

Livestreaming in Asia: Meet the stars of 'shoppertainment'

As Covid-19 keeps millions of people at home, the popularity of "shoppertainment" has skyrocketed in Asia.
BBC News
Officials Concerned With Russia’s COVID Vaccine [Video]

Officials Concerned With Russia’s COVID Vaccine

Officials Concerned With Russia’s COVID Vaccine

Credit: Wochit News    Duration: 00:26Published
Covid update: India's 10 lakh gap; New Zealand polls under cloud; WB lockdown [Video]

Covid update: India's 10 lakh gap; New Zealand polls under cloud; WB lockdown

From the gap between India's active and discharged cases increasing to almost 10 lakh, to another member of Narendra Modi's cabinet testing positive for infection - here are the top news updates on the Covid-19 pandemic. Shripad Yesso Naik is the fifth Union minister to test positive. Home minister Amit Shah was the first member of the Union cabinet to be infected. Naik who is the Minister of State (Independent Charge) of Ministry of Ayurved, Yoga, Naturopathy, Unani, Siddha & Homoeopathy (AYUSH), and Minister of State in the Ministry of Defence, is in home isolation. In Maharashtra, over 11,300 police personnel have so far been infected. While the death toll among Maharashtra cops has crossed 120, over 9,100 have recovered, and there are 2,000-plus active cases. In West Bengal, the state government withdrew the order regarding complete lockdown on August 28. However, lockdown orders remain in operation for August 20, 21, 27 and 31. India's total case tally has crossed 23.29 lakh, while the death toll has crossed 46,000. Over 16.39 lakh patients have been discharged so far. In international news, the discovery of a new case after 102 days in New Zealand has led the Prime Minister, Jacinda Ardern, to say that postponement of the upcoming general elections is a possibility. Meanwhile, the Russian government said that the first batch of its Covid vaccine is likely to be released within two weeks. Russia has become the first country to declare a vaccine ready for use. Watch the full video for more updates regarding the spread of the Sars-CoV-2 coronavirus.

Credit: HT Digital Content    Duration: 02:26Published

Related videos from verified sources

'WHO should've researched independently’: CSIR welcomes HCQ trial resumption [Video]

'WHO should've researched independently’: CSIR welcomes HCQ trial resumption

Council of Scientific and Industrial Research (CSIR) welcomed WHO’s move to resume hydroxychloroquine trials. WHO on Thursday said HCQ will return to solidarity trial for potential treatment for..

Credit: HT Digital Content     Duration: 01:41Published
Hydroxychloroquine no better than placebo, study finds [Video]

Hydroxychloroquine no better than placebo, study finds

The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was ineffective in preventing infection in people exposed to the coronavirus, according to a widely anticipated..

Credit: Reuters - Politics     Duration: 01:56Published
WHO To Reportedly Resume Hydroxychloroquine Trial [Video]

WHO To Reportedly Resume Hydroxychloroquine Trial

The WHO will resume a key trial.

Credit: Geo Beats     Duration: 01:06Published

Tweets about this